An initial screening for HIV-associated neurocognitive disorders of HIV-1 infected patients in China

Journal of NeuroVirology

Volumn 18, Issue 2, 2012, Pages 120-126

  Zhang, Yulin ^a   Qiao, Luxin ^b   Ding, Wei ^b   Wei, Feili ^a   Zhao, Qingxia ^c   Wang, Xicheng ^d   Shi, Ying ^a   Li, Ning ^a   Smith, Davey ^e   Chen, Dexi ^a,b  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

^c Infectious Diseases Hospital of Henan Province   (China)

^d AIDS Care Center   (China)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

AIDS; Clinical manifestation; HIV associated neurocognitive disorders; Prevalence

Indexed keywords

ANTIRETROVIRUS AGENT;

ADULT; ARTICLE; BEHAVIOR DISORDER; BLOOD SAFETY; CD4 LYMPHOCYTE COUNT; CEREBROSPINAL FLUID; CHINA; CLINICAL ASSESSMENT; CLINICAL FEATURE; COGNITIVE DEFECT; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HIV ASSOCIATED DEMENTIA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; INTERNATIONAL HIV DEMENTIA SCALE; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NEUROPSYCHOLOGICAL TEST; PREDICTIVE VALUE; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RATING SCALE; SCREENING TEST; SENSITIVITY AND SPECIFICITY; SYMPTOM; VIRUS LOAD; WESTERN BLOTTING;

ADULT; AIDS DEMENTIA COMPLEX; ANTI-HIV AGENTS; CD4 LYMPHOCYTE COUNT; CHINA; CROSS-SECTIONAL STUDIES; FEMALE; HIV-1; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PREVALENCE; SEVERITY OF ILLNESS INDEX; T-LYMPHOCYTES; VIRAL LOAD;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 84863659053     PISSN: 13550284     EISSN: 15382443     Source Type: Journal    
DOI: 10.1007/s13365-012-0089-y     Document Type: Article

References (22)

1. Antinori A, Arendt G, Becker JT, Brew BJ, Byrd DA, Cherner M, Clifford DB, Cinque P, Epstein LG, Goodkin K, Gisslen M, Grant I, Heaton RK, Joseph J, Marder K, Marra CM, McArthur JC, Nunn M, Price RW, Pulliam L, Robertson KR, Sacktor N, Valcour V, Wojna VE (2007a) Updated research nosology for HIVassociated neurocognitive disorders. Neurology 69:1789-1799 (Pubitemid 350059308)
2. Antinori A, Trotta MP, Lorenzini P, Torti C, Gianotti N, Maggiolo F, Ceccherini-Silberstein F, Nasto P, Castagna A, De Luca A, Mussini C, Andreoni M, Perno CF (2007b) Virological response to salvage therapy in HIV-infected persons carrying the reverse transcriptase K65R mutation. Antivir Ther 12:1175-1183
3. Boisse L, Gill MJ, Power C (2008) HIV infection of the central nervous system: clinical features and neuropathogenesis. Neurol Clin 26:799-819, x (Pubitemid 352037443)
4. Carey CL, Woods SP, Rippeth JD, Gonzalez R, Moore DJ, Marcotte TD, Grant I, Heaton RK (2004) Initial validation of a screening battery for the detection of HIV-associated cognitive impairment. Clin Neuropsychol 18:234-248 (Pubitemid 39180728)
5. Cysique LA, Brew BJ (2011) Prevalence of non-confounded HIVassociated neurocognitive impairment in the context of plasma HIV RNA suppression. J Neurovirol 17:176-183
6. Ellis RJ, Badiee J, Vaida F, Letendre S, Heaton RK, Clifford D, Collier AC, Gelman B, McArthur J, Morgello S, McCutchan JA, Grant I (2011) CD4 nadir is a predictor of HIV neurocognitive impairment in the era of combination antiretroviral therapy. AIDS 25:1747-1751
7. Gandhi NS, Skolasky RL, Peters KB, Moxley RTT, Creighton J, Roosa HV, Selnes OA, McArthur J, Sacktor N (2011) A comparison of performance-based measures of function in HIV-associated neurocognitive disorders. J Neurovirol 17:159-165
8. Heaton RK, Grant I, Butters N, White DA, Kirson D, Atkinson JH, McCutchan JA, Taylor MJ, Kelly MD, Ellis RJ et al (1995) The HNRC 500-neuropsychology of HIV infection at different disease stages. HIV Neurobehavioral Research Center. J Int Neuropsychol Soc 1:231-251
9. Heaton RK, Cysique LA, Jin H, Shi C, Yu X, Letendre S, Franklin DR, Ake C, Vigil O, Atkinson JH, Marcotte TD, Grant I, Wu Z (2008) Neurobehavioral effects of human immunodeficiency virus infection among former plasma donors in rural China. J Neurovirol 14:536-549
10. Heaton RK, Franklin DR, Ellis RJ, McCutchan JA, Letendre SL, Leblanc S, Corkran SH, Duarte NA, Clifford DB, Woods SP, Collier AC, Marra CM, Morgello S, Mindt MR, Taylor MJ, Marcotte TD, Atkinson JH, Wolfson T, Gelman BB, McArthur JC, Simpson DM, Abramson I, Gamst A, Fennema-Notestine C, Jernigan TL, Wong J, Grant I (2011) HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors. J Neurovirol 17:3-16
11. Kandanearatchi A, Williams B, Everall IP (2003) Assessing the efficacy of highly active antiretroviral therapy in the brain. Brain Pathol 13:104-110 (Pubitemid 36133797)
12. Kaul M, Zheng J, Okamoto S, Gendelman HE, Lipton SA (2005) HIV-1 infection and AIDS: consequences for the central nervous system. Cell Death Differ 12(Suppl 1):878-892 (Pubitemid 41038393)
13. Kim DH, Jewison DL, Milner GR, Rourke SB, Gill MJ, Power C (2001) Neurocognitive symptoms and impairment in an HIV community clinic. Can J Neurol Sci 28:228-231 (Pubitemid 32785927)
14. Minagar A, Commins D, Alexander JS, Hoque R, Chiappelli F, Singer EJ, Nikbin B, Shapshak P (2008) NeuroAIDS: characteristics and diagnosis of the neurological complications of AIDS. Mol Diagn Ther 12:25-43 (Pubitemid 351281697)
15. Owe-Larsson B, Sall L, Salamon E, Allgulander C (2009) HIV infection and psychiatric illness. Afr J Psychiatry (Johannesburg) 12:115-128
16. Pascual-Sedano B, Iranzo A, Marti-Fabregas J, Domingo P, Escartin A, Fuster M, Barrio JL, Sambeat MA (1999) Prospective study of new-onset seizures in patients with human immunodeficiency virus infection: etiologic and clinical aspects. Arch Neurol 56:609-612 (Pubitemid 29218157)
17. Pumpradit W, Ananworanich J, Lolak S, Shikuma C, Paul R, Siangphoe U, Chaoniti N, Kaew-On P, Paris R, Ruxrungtham K, Valcour V (2010) Neurocognitive impairment and psychiatric comorbidity in well-controlled human immunodeficiency virus-infected Thais from the 2NN Cohort Study. J Neurovirol 16:76-82
18. Robertson KR, Smurzynski M, Parsons TD, Wu K, Bosch RJ, Wu J, McArthur JC, Collier AC, Evans SR, Ellis RJ (2007) The prevalence and iHANDdence of neurocognitive impairment in the HAART era. AIDS 21:1915-1921 (Pubitemid 47329768)
19. Robinson-Papp J, Elliott KJ, Simpson DM (2009) HIV-related neurocognitive impairment in the HAART era. Curr HIV/AIDS Rep 6:146-152
20. Sacktor NC, Wong M, Nakasujja N, Skolasky RL, Selnes OA, Musisi S, Robertson K, McArthur JC, Ronald A, Katabira E (2005) The International HIV Dementia Scale: a new rapid screening test for HIV dementia. AIDS 19:1367-1374 (Pubitemid 41800672)
21. Simioni S, Cavassini M, Annoni JM, Rimbault Abraham A, Bourquin I, Schiffer V, Calmy A, Chave JP, Giacobini E, Hirschel B, Du Pasquier RA (2010) Cognitive dysfunction in HIV patients despite long-standing suppression of viremia. AIDS 24:1243-1250
22. Woods SP, Moore DJ, Weber E, Grant I (2009) Cognitive neuropsychology of HIV-associated neurocognitive disorders. Neuropsychol Rev 19:152-168